$3.42
-0.29-7.82%
At close: Jul 15, 5:00 PM EST
$3.45
-0.26-6.90%
Pre-Market: 8:40 AM EST
Fortress Biotech Inc Earnings Estimates
FBIONASDAQ
Fortress Biotech Earnings Estimates, EPS & Revenue | NASDAQ:FBIO
Fortress Biotech (FBIO) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-0.20 and quarterly revenue of $18.30M.
In the most recent quarter (Q1), Fortress Biotech reported EPS of $2.82, beating estimates of $-0.08 by 36.25%. Revenue came in at $16.04M, missing the estimate of $16.34M by 0.02%.
Over the last 4 quarters, Fortress Biotech has averaged an EPS surprise of 10.06% and a revenue surprise of 0.20%.
Earnings Date
Aug 13
EPS Estimate
$-0.200
Quarterly Revenue Estimate
$18.30M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$66.16M
Fortress Biotech Earnings History
Analyze the earnings history of Fortress Biotech using advanced sorting and filters.
Loading calendar...
Fortress Biotech (FBIO) Earnings Per Share
The chart below shows Fortress Biotech's reported EPS compared to analyst estimates over recent quarters.
Fortress Biotech (FBIO) Revenue
The chart below shows Fortress Biotech's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Fortress Biotech (NASDAQ:FBIO) reporting earnings?
Fortress Biotech (FBIO) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Fortress Biotech (NASDAQ:FBIO)?
The Actual EPS was $2.82, which beat the estimate of $-0.08.
What were Fortress Biotech’s (NASDAQ:FBIO) revenues?
The Actual Revenue was $16.04M, which missed the estimate of $16.34M.
